SQZ Biotechnologies Co (SQZ)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN, MA 02472

SQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ Biotechnologies offers the unique ability to deliver multiple materials into many patient cell types to engineer what SQZ Biotechnologies believes can be an unprecedented range of potential therapeutics for a variety of diseases. SQZ Biotechnologies has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and to improve the patient experience over existing cell therapy approaches. With accelerated production timelines under 24 hours and the opportunity to eliminate preconditioning and lengthy hospital stays, its goal is to use the SQZ approach to establish a new paradigm for cell therapies. The Company's first therapeutic applications aim to leverage the potential to generate target-specific immune responses, both in activation for the treatment of solid tumors and immune tolerance for the treatment of unwanted immune reactions and autoimmune diseases.

Data as of 2021-07-25 17:52:43 -0400
Market Cap388.392 Million Shares Outstanding27.882 Million Avg 30-day Volume158.933 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE0.3 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low36.49 / 11.15 Next Earnings Date2021-08-10 Price to Cash FLow (P/CF) -26.1507
Data provided by IEX Cloud
View SEC Filings from SQZ instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 46 36 27.78% 15 (0.88%) 7 (0.41%) 114.29%
13F shares: 10.945 Million 7.25 Million 50.96% 3.35 Million 2.446 Million 36.99%
% Ownership 39.2719 29.3336 33.88% 12.0206 9.8942 21.49%
New Positions: 12 35 -65.71% 9 7 28.57%
Increased Positions 21 3
Closed Positions 2 1
Reduced Positions 7 2
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SQZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SQZ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VINK PATRICK V.J.J.

  • Director
21,000 2021-07-01 2

COULIE BERNARD

  • Director
21,000 2021-07-01 2

SCHULMAN AMY W

  • Director
  • 10% Owner
10,500 2021-06-15 4

SRIVASTAVA SAPNA

  • Director
10,500 2021-06-15 3

BOLNO PAUL

  • Director
10,500 2021-06-15 3

GARG PUSHKAL

  • Director
10,500 2021-06-15 3

JENSEN KLAVS F.

  • Director
10,500 2021-06-15 4

ELIA MARC

  • Director
10,500 2021-06-15 3

SCHEGERIN MARC

  • Director
10,500 2021-06-15 3

SHAREI ARMON PRESIDENT AND CEO

  • Officer
  • Director
455,699 2021-02-27 5

BERNSTEIN HOWARD PHD MD CHIEF SCIENTIFIC OFFICER

  • Officer
72,900 2021-02-23 3

KNOPF LAWRENCE J GENERAL COUNSEL

  • Officer
48,100 2021-02-23 3

FIRST DAVID CHIEF PEOPLE OFFICER

  • Officer
28,900 2021-02-23 3

LOXAM TERI CHIEF FINANCIAL OFFICER

  • Officer
75,950 2021-02-23 3

ROSEN OLIVER CHIEF MEDICAL OFFICER

  • Officer
75,625 2021-02-23 3

ZAJIC MICAH CHIEF BUSINESS OFFICER

  • Officer
22,339 2021-02-23 4

TEMASEK HOLDINGS (PRIVATE) LTD

  • 10% Owner
4,402,848 2020-11-03 2

INVUS PUBLIC EQUITIES, L.P.

MINNE PASCAL

ARTAL INTERNATIONAL S.C.A.

ARTAL INTERNATIONAL MANAGEMENT S.A.

ARTAL GROUP S.A.

WESTEND S.A.

STICHTING ADMINISTRATIEKANTOOR WESTEND

ARTAL TREASURY LTD

INVUS PUBLIC EQUITIES ADVISORS, LLC

  • 10% Owner
No longer subject to file 2020-11-03 2

AMY SCHULMAN, AS TRUSTEE THE ARMON R. SHAREI IRREVOCABLE GST TRUST OF 2016, U/D/T DATED DECEMBER 29, 2016

  • 10% Owner
No longer subject to file 2020-11-03 2

POLARIS MANAGEMENT CO. VII, L.L.C.

POLARIS ENTREPRENEURS' FUND VII, L.P.

POLARIS PARTNERS VII, L.P.

  • 10% Owner
5,205,292 2020-11-03 2

AMERICAN INTERNATIONAL GROUP INC

  • 10% Owner
No longer subject to file 2020-11-03 3

LANGER ROBERT

  • 10% Owner
243,987 2020-10-29 1

MOESSLINGER ERIC

  • Director
0 2020-10-29 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

COULIE BERNARD - Director

2021-07-01 17:19:12 -0400 2021-07-01 A 21,000 a 21,000 direct

VINK PATRICK V.J.J. - Director

2021-07-01 17:20:55 -0400 2021-07-01 A 21,000 a 21,000 direct

GARG PUSHKAL - Director

2021-06-17 17:16:09 -0400 2021-06-15 A 10,500 a 10,500 direct

ELIA MARC - Director

2021-06-17 17:26:00 -0400 2021-06-15 A 10,500 a 10,500 direct

JENSEN KLAVS F. - Director

2021-06-17 17:15:50 -0400 2021-06-15 A 10,500 a 10,500 direct

SCHEGERIN MARC - Director

2021-06-17 17:16:37 -0400 2021-06-15 A 10,500 a 10,500 direct

SRIVASTAVA SAPNA - Director

2021-06-17 17:16:04 -0400 2021-06-15 A 10,500 a 10,500 direct

SCHULMAN AMY W - Director - > 10% Owner

2021-06-17 17:16:15 -0400 2021-06-15 A 10,500 a 10,500 direct

BOLNO PAUL - Director

2021-06-17 17:15:30 -0400 2021-06-15 A 10,500 a 10,500 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 16:45:03 UTC -0.5546 0.6346 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 16:15:02 UTC -0.5546 0.6346 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 15:45:03 UTC -0.5546 0.6346 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 15:15:03 UTC -0.5546 0.6346 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 14:45:02 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 14:15:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 13:45:02 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 13:15:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-28 12:45:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 22:15:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 21:45:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 21:15:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 20:45:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 20:15:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 19:45:02 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 19:15:02 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 18:45:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 18:15:02 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 17:45:03 UTC -0.5549 0.6349 200000
SQZ BIOTECHNOLOGIES CO SQZ 2021-07-27 17:15:03 UTC -0.5549 0.6349 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments